Bonvini Ezio
- SEC CIK
- 0001588365
No open-market purchases or sales filed in the past year.
Current role at each company
- MGNX Macrogenics IncSr VP, Research & CSOas of Aug 18, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Bonvini Ezio as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 7, 2024 (view filing) | Feb 7 | Same day | Bonvini EzioSr VP, Research & CSO | SSale | −3.33K | $18.00 | −$60.0K | −4.5%71.3K after | 10b5-1 |
| Feb 2, 2024 (view filing) | Feb 1 | 1 day | Bonvini EzioSr VP, Research & CSO | SSale | −13.3K | $15.00 | −$199.7K | −15.1%74.7K after | 10b5-1 |
| Jan 22, 2024 (view filing) | Jan 19 | 3 days | Bonvini EzioSr VP, Research & CSO | SSale | −13.3K | $12.00 | −$159.8K | −13.1%88.0K after | 10b5-1 |
| Dec 21, 2023 (view filing) | Dec 20 | 1 day | Bonvini EzioSr VP, Research & CSO | SSale | −18.9K | $10.08 | −$190.3K | −15.7%101.3K after | 10b5-1 |